ESC Premium Access

Prevention of thromboembolism and atrial remodelling in atrial fibrillation

Event: ESC CONGRESS 2019
Topic: Atrial Fibrillation (AF)
Session type: Rapid Fire Abstracts
Date: 2 September 2019
Time: 08:30 - 10:00

Congress Session

9 presentations in this session

Equally high detection rates of atrial fibrillation in patients after a TIA and stroke by systematic ECG monitoring with an implanted device: SPIDER-AF study

Speaker: Doctor F. Goss (Munich, DE)
Thumbnail

Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience

Speaker: Doctor A. Graffigna (Trento, IT)
Thumbnail

Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

Speaker: Doctor O. Rutherford (Sarpsborg, NO)
Thumbnail

Non-vitamin K antagonist oral anticoagulants are safe and effective alternatives to warfarin across subgroups by renal function: results from Danish registries

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)
Thumbnail

High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

Speaker: Professor P. Hjemdahl (Stockholm, SE)
Thumbnail

Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer

Speaker: Doctor I. Cavallari (Rome, IT)
Thumbnail

Interactions between metabolism regulator adiponectin and intrinsic cardiac autonomic nervous system: a potential treatment target for atrial fibrillation

Speaker: Professor L. Yu (Wuhan, CN)
Thumbnail

Orthogonal P wave morphology, traditional P wave indices, and the risk of atrial fibrillation in the general population

Speaker: Doctor A. Eranti (Turku, FI)
Thumbnail

Relation of atrial remodeling to circulating biomarkers of myocardial fibrosis and apoptotic microparticles in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)
Thumbnail

9 speakers from this session

Doctor Franz Goss

Heart Center Alter Hof, Munich (Germany)
1 presentation
0 follower

Doctor Angelo Graffigna

Santa Chiara Hospital in Trento, Department of Cardiology, Trento (Italy)
0 follower

Doctor Ole-Christian Walter Rutherford

Sykehuset Ostfold Kalnes, Sarpsborg (Norway)
0 follower

Doctor Anders Nissen Bonde

Gentofte University Hospital, Gentofte (Denmark)
0 follower

Professor Paul Hjemdahl

Karolinska University Hospital, Stockholm (Sweden)
0 follower

Doctor Ilaria Cavallari

University Campus Bio-Medico of Rome, Rome (Italy)
1 presentation
0 follower

Professor Lilei Yu

Renmin Hospital of Wuhan University, Wuhan (China)
0 follower

Doctor Antti Eranti

Turku University Hospital, Turku (Finland)
0 follower

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

This platform is supported by

logo Novo Nordisk